Literature DB >> 24192009

Strategies to improve repeat fecal occult blood testing cancer screening.

Terry C Davis1, Connie L Arnold, Charles L Bennett, Michael S Wolf, Cristalyn Reynolds, Dachao Liu, Alfred Rademaker.   

Abstract

BACKGROUND: A comparative effectiveness intervention by this team improved initial fecal occult blood testing (FOBT) rates from 3% to 53% among community clinic patients. The purpose of this study was to evaluate the effectiveness and costs associated with a literacy-informed intervention on repeat FOBT testing.
METHODS: Between 2008 and 2011, a three-arm quasi-experiential comparative effectiveness evaluation was conducted in eight community clinics in Louisiana. Clinics were randomly assigned to receive: enhanced care, a screening recommendation, and FOBT kit annually; a brief educational intervention where patients additionally received a literacy appropriate pamphlet and simplified FOBT instructions; or nurse support where a nurse manager provided the education and followed up with phone support. In year 2, all materials were mailed. The study consisted of 461 patients, ages 50 to 85 years, with a negative initial FOBT.
RESULTS: Repeat FOBT rates were 38% enhanced care, 33% education, and 59% with nurse support (P = 0.017). After adjusting for age, race, gender, and literacy, patients receiving nurse support were 1.46 times more likely to complete repeat FOBT screening than those receiving education [95% confidence interval (CI), 1.14-1.06; P = 0.002] and 1.45 times more likely than those in enhanced care but this was not significant (95% CI, 0.93-2.26; P = 0.10). The incremental cost per additional person screened was $2,450 for nurse over enhanced care.
CONCLUSION: A mailed pamphlet and FOBT with simplified instructions did not improve annual screening. IMPACT: Telephone outreach by a nurse manager was effective in improving rates of repeat FOBT, yet this may be too costly for community clinics.

Entities:  

Mesh:

Year:  2013        PMID: 24192009      PMCID: PMC3894742          DOI: 10.1158/1055-9965.EPI-13-0795

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  47 in total

1.  Fecal occult blood test use by Kansas medicare beneficiaries.

Authors:  K K Engelman; E F Ellerbeck; J S Ahluwalia; N Nazir; A Velasco
Journal:  Prev Med       Date:  2001-12       Impact factor: 4.018

2.  Trends in colorectal cancer screening with home-based fecal occult blood tests in adults ages 50 to 64 years, 2000-2008.

Authors:  Priti Bandi; Vilma Cokkinides; Robert A Smith; Ahmedin Jemal
Journal:  Cancer       Date:  2012-03-20       Impact factor: 6.860

3.  Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.

Authors:  Montse Garcia; Josep Maria Borràs; Gemma Binefa; Núria Milà; Josep Alfons Espinàs; Víctor Moreno
Journal:  Eur J Cancer Prev       Date:  2012-01       Impact factor: 2.497

4.  Comparative effectiveness research in cancer: what has been funded and what knowledge gaps remain?

Authors:  Russell E Glasgow; V Paul Doria-Rose; Muin J Khoury; Mohammed Elzarrad; Martin L Brown; Kurt C Stange
Journal:  J Natl Cancer Inst       Date:  2013-04-11       Impact factor: 13.506

Review 5.  Barriers to screening for colorectal cancer.

Authors:  Richard C Wender
Journal:  Gastrointest Endosc Clin N Am       Date:  2002-01

6.  Social learning theory and the Health Belief Model.

Authors:  I M Rosenstock; V J Strecher; M H Becker
Journal:  Health Educ Q       Date:  1988

7.  Inequalities in adoption of cancer screening from a diffusion of innovation perspective: identification of late adopters.

Authors:  Myung-Il Hahm; Eun-Cheol Park; Kui Son Choi; Hoo-Yeon Lee; Jae-Hyun Park; Sohee Park
Journal:  Cancer Epidemiol       Date:  2010-10-13       Impact factor: 2.984

8.  Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial.

Authors:  Thomas D Sequist; Alan M Zaslavsky; Richard Marshall; Robert H Fletcher; John Z Ayanian
Journal:  Arch Intern Med       Date:  2009-02-23

9.  Implementing colorectal cancer screening in community health centers: addressing cancer health disparities through a regional cancer collaborative.

Authors:  Stephen H Taplin; David Haggstrom; Tracy Jacobs; Ada Determan; Jennifer Granger; Wanda Montalvo; William M Snyder; Susan Lockhart; Ahmed Calvo
Journal:  Med Care       Date:  2008-09       Impact factor: 2.983

10.  Improving fecal occult blood testing compliance using a mailed educational reminder.

Authors:  Jeffrey K Lee; Veronica Reis; Shanglei Liu; Lorraine Conn; Erik J Groessl; Theodore G Ganiats; Samuel B Ho
Journal:  J Gen Intern Med       Date:  2009-09-23       Impact factor: 5.128

View more
  14 in total

1.  Third Annual Fecal Occult Blood Testing in Community Health Clinics.

Authors:  Connie L Arnold; Alfred Rademaker; Michael S Wolf; Dachao Liu; Jill Hancock; Terry C Davis
Journal:  Am J Health Behav       Date:  2016-05

2.  Comparative Effectiveness of Multifaceted Outreach to Initiate Colorectal Cancer Screening in Community Health Centers: A Randomized Controlled Trial.

Authors:  Shira N Goldman; David T Liss; Tiffany Brown; Ji Young Lee; David R Buchanan; Kate Balsley; Ana Cesan; Jordan Weil; Bridget H Garrity; David W Baker
Journal:  J Gen Intern Med       Date:  2015-03-27       Impact factor: 5.128

3.  An economic evaluation of colorectal cancer screening in primary care practice.

Authors:  Richard T Meenan; Melissa L Anderson; Jessica Chubak; Sally W Vernon; Sharon Fuller; Ching-Yun Wang; Beverly B Green
Journal:  Am J Prev Med       Date:  2015-06       Impact factor: 5.043

4.  Changes in Colorectal Cancer Screening Knowledge, Behavior, Beliefs, Self-Efficacy, and Barriers among Community Health Clinic Patients after a Health Literacy Intervention.

Authors:  Connie L Arnold; Alfred Rademaker; Dachao Liu; Terry C Davis
Journal:  J Community Med Health Educ       Date:  2017-01-13

5.  High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy?

Authors:  B A Mahal; M-H Chen; C L Bennett; M W Kattan; O Sartor; K Stein; A V D'Amico; P L Nguyen
Journal:  Ann Oncol       Date:  2015-04-28       Impact factor: 32.976

6.  Follow-up approaches to a health literacy intervention to increase colorectal cancer screening in rural community clinics: A randomized controlled trial.

Authors:  Connie L Arnold; Alfred W Rademaker; James D Morris; Laurie Anne Ferguson; Gary Wiltz; Terry C Davis
Journal:  Cancer       Date:  2019-07-29       Impact factor: 6.860

7.  A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics.

Authors:  Stacy N Davis; Shannon M Christy; Enmanuel A Chavarria; Rania Abdulla; Steven K Sutton; Alyssa R Schmidt; Susan T Vadaparampil; Gwendolyn P Quinn; Vani N Simmons; Chukwudi B Ufondu; Chitra Ravindra; Ida Schultz; Richard G Roetzheim; David Shibata; Cathy D Meade; Clement K Gwede
Journal:  Cancer       Date:  2016-12-01       Impact factor: 6.860

8.  Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis.

Authors:  Michael K Dougherty; Alison T Brenner; Seth D Crockett; Shivani Gupta; Stephanie B Wheeler; Manny Coker-Schwimmer; Laura Cubillos; Teri Malo; Daniel S Reuland
Journal:  JAMA Intern Med       Date:  2018-12-01       Impact factor: 21.873

9.  Economics of Multicomponent Interventions to Increase Breast, Cervical, and Colorectal Cancer Screening: A Community Guide Systematic Review.

Authors:  Giridhar Mohan; Sajal K Chattopadhyay; Donatus U Ekwueme; Susan A Sabatino; Devon L Okasako-Schmucker; Yinan Peng; Shawna L Mercer; Anilkrishna B Thota
Journal:  Am J Prev Med       Date:  2019-08-30       Impact factor: 5.043

10.  Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.

Authors:  Carrie M Nielson; William M Vollmer; Amanda F Petrik; Erin M Keast; Beverly B Green; Gloria D Coronado
Journal:  J Gen Intern Med       Date:  2019-01-25       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.